Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Candida antigen is an effective and promising treatment for alopecia areata.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.